Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Current Taxes (2021 - 2025)

Historic Current Taxes for Collegium Pharmaceutical (COLL) over the last 5 years, with Q3 2025 value amounting to $797000.0.

  • Collegium Pharmaceutical's Current Taxes fell 2523.45% to $797000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $797000.0, marking a year-over-year decrease of 2523.45%. This contributed to the annual value of $8.5 million for FY2024, which is 29911.05% up from last year.
  • According to the latest figures from Q3 2025, Collegium Pharmaceutical's Current Taxes is $797000.0, which was down 2523.45% from $328000.0 recorded in Q2 2025.
  • Collegium Pharmaceutical's Current Taxes' 5-year high stood at $14.1 million during Q1 2024, with a 5-year trough of $36000.0 in Q3 2021.
  • Its 5-year average for Current Taxes is $3.3 million, with a median of $931500.0 in 2024.
  • Its Current Taxes has fluctuated over the past 5 years, first soared by 29911.05% in 2024, then tumbled by 3834.59% in 2025.
  • Quarter analysis of 5 years shows Collegium Pharmaceutical's Current Taxes stood at $622000.0 in 2021, then soared by 228.46% to $2.0 million in 2022, then grew by 4.55% to $2.1 million in 2023, then soared by 299.11% to $8.5 million in 2024, then crashed by 90.65% to $797000.0 in 2025.
  • Its last three reported values are $797000.0 in Q3 2025, $328000.0 for Q2 2025, and $9.0 million during Q1 2025.